Related Experiment Videos
Epstein-Barr virus and interactions with human retroviruses
J S Pagano1, S Kenney, D Markovitz
1Department of Medicine, University of North Carolina, Chapel Hill 27599.
Journal of Virological Methods
|September 1, 1988
Summary
Epstein-Barr virus (EBV) and human immunodeficiency virus (HIV) interact, with EBV potentially enabling HIV infection in B-lymphocytes. This study explores EBV
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Accumulating evidence suggests interactions between Epstein-Barr virus (EBV) and human immunodeficiency virus (HIV).
- Coinfection of B-lymphocytes by EBV and HIV is observed.
- Increased prevalence of active EBV and frequent EBV-related B-cell lymphomas in AIDS patients indicate a link.
Purpose of the Study:
- To summarize mechanisms of Epstein-Barr virus (EBV) transactivation of human immunodeficiency virus (HIV) long terminal repeat (LTR) constructs.
- To present preliminary data on human T-cell leukemia virus type 1 (HTLV-1) activation of an EBV promoter.
- To investigate the role of EBV in facilitating HIV infection of B-lymphocytes.
Main Methods:
- Review of mechanisms for EBV-mediated transactivation of HIV LTR.
- Experimental analysis of EBV-transformed cord-blood B-lymphocytes for HIV infection.
- Presentation of preliminary data on HTLV-1 activation of EBV promoter.
Main Results:
- EBV preinfection and transformation enable HIV infection of cord-blood B-lymphocytes.
- Mechanisms of EBV gene product-mediated transactivation of HIV LTR are summarized.
- Preliminary data suggest HTLV-1 can activate EBV promoters.
Conclusions:
- EBV plays a crucial role in facilitating HIV infection of B-lymphocytes.
- Understanding these viral interactions is vital for managing coinfections and associated malignancies.
- Further research into HTLV-1 and EBV promoter interactions is warranted.